FIGS, Inc. (NYSE:FIGS – Get Free Report) CFO Sarah Oughtred sold 10,515 shares of the company’s stock in a transaction on Wednesday, January 7th. The shares were sold at an average price of $11.50, for a total value of $120,922.50. Following the completion of the sale, the chief financial officer owned 834,830 shares of the company’s stock, valued at approximately $9,600,545. This trade represents a 1.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Sarah Oughtred also recently made the following trade(s):
- On Tuesday, November 4th, Sarah Oughtred sold 22,745 shares of FIGS stock. The stock was sold at an average price of $7.39, for a total transaction of $168,085.55.
FIGS Trading Down 1.8%
Shares of FIGS stock traded down $0.21 on Thursday, reaching $11.77. 2,350,768 shares of the company were exchanged, compared to its average volume of 1,947,864. FIGS, Inc. has a fifty-two week low of $3.57 and a fifty-two week high of $12.35. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of 117.70 and a beta of 1.30. The stock has a fifty day moving average price of $10.48 and a 200-day moving average price of $8.05.
Analysts Set New Price Targets
A number of research firms recently issued reports on FIGS. Wall Street Zen lowered shares of FIGS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 13th. Telsey Advisory Group reissued a “market perform” rating and issued a $9.00 price target (up from $7.00) on shares of FIGS in a report on Monday, November 3rd. BTIG Research upped their price objective on shares of FIGS from $12.00 to $15.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Wolfe Research raised FIGS to a “buy” rating in a research report on Wednesday, December 10th. Finally, Morgan Stanley upped their price target on FIGS from $5.25 to $7.50 and gave the company an “equal weight” rating in a report on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, FIGS presently has a consensus rating of “Hold” and an average target price of $9.60.
Get Our Latest Stock Analysis on FIGS
Institutional Trading of FIGS
A number of institutional investors have recently bought and sold shares of the business. Bamco Inc. NY raised its stake in FIGS by 2.2% during the 2nd quarter. Bamco Inc. NY now owns 59,974,407 shares of the company’s stock worth $338,256,000 after buying an additional 1,302,823 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of FIGS by 9.0% in the second quarter. Ameriprise Financial Inc. now owns 13,936,468 shares of the company’s stock valued at $78,602,000 after buying an additional 1,144,962 shares during the period. Vanguard Group Inc. increased its position in shares of FIGS by 4.6% during the third quarter. Vanguard Group Inc. now owns 9,609,320 shares of the company’s stock worth $64,286,000 after acquiring an additional 425,189 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of FIGS by 1.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,417,008 shares of the company’s stock valued at $29,549,000 after purchasing an additional 70,660 shares during the period. Finally, Marshall Wace LLP boosted its holdings in FIGS by 45.7% during the third quarter. Marshall Wace LLP now owns 2,585,258 shares of the company’s stock worth $17,295,000 after purchasing an additional 810,719 shares during the last quarter. Institutional investors and hedge funds own 92.21% of the company’s stock.
FIGS Company Profile
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
Read More
- Five stocks we like better than FIGS
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- YDES Could Be 2026’s Biotech Breakthrough
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
